AI-generated analysis. Always verify with the original filing.
Esperion Therapeutics, Inc. furnished a press release as Exhibit 99.1 under Item 2.02 on March 10, 2026, regarding results of operations. The filing includes Exhibit 99.1 (Press Release) and Exhibit 104 (cover page).
Event Type
Disclosure
Mandatory
Variant
8-K
and in Exhibit 99.1 attached hereto is intended to be furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 193
. Financial Statements and Exhibits. Exhibit No. Description 99.1 Press Release dated March 10 , 202 6 104 The cover page from this Current Report on Form 8-K,